Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,950.00
+5.00 (0.10%)
At close: Mar 12, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 55.12 billion as of March 13, 2026. Its market cap has decreased by -12.98% in one year.
Market Cap
55.12B
Enterprise Value
49.91B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,950.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 55.12B, a decrease of -40.53%. That is a compound annual growth rate of -34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 55.12B | -23.85% |
| Dec 30, 2025 | 72.38B | 26.47% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BBIA Co., Ltd. | 82.82B |
| ERCOHS Agricultural Corporation Co.,Ltd | 82.03B |
| Black Yak I&C Co.,Ltd | 80.08B |
| GITSN | 78.40B |
| ALT Co., Ltd. | 75.32B |
| Laseroptek | 61.14B |
| JNB Co., Ltd. | 51.83B |
| Korea No.14 Special Purpose Acquisition | 47.95B |